Enloplatin

CAS No. 111523-41-2

Enloplatin( —— )

Catalog No. M36166 CAS No. 111523-41-2

Enloplatin is a carboplatin analog that has a partial role in advanced ovarian cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 70 In Stock
10MG 104 In Stock
25MG 201 In Stock
50MG 269 In Stock
100MG 398 In Stock
200MG 569 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Enloplatin
  • Note
    Research use only, not for human use.
  • Brief Description
    Enloplatin is a carboplatin analog that has a partial role in advanced ovarian cancer.
  • Description
    Enloplatin is a carboplatin analog that has a partial role in advanced ovarian cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    111523-41-2
  • Formula Weight
    481.4
  • Molecular Formula
    C13H22N2O5Pt
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C2(C(=O)[O-][Pt+2]3([O-]1)[NH2]CC4(C[NH2]3)CCOCC4)CCC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 7-(4-hydroxy-3-metho...

    7-(4-hydroxy-3-methoxyphenyl)-1-phenylhept-4-en-3-one (DPHB) is a natural product for research related to life sciences.

  • Gastrin-Releasing Pe...

    Gastrin-releasing peptide is a regulatory human peptide that elicits gastrin release and regulates gastric acid secretion and enteric motor function.

  • MRT-2359

    MRT-2359 is a potent and orally available GSPT1 reducer with antitumour activity.MRT-2359 inhibits the growth of drug-resistant non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells.MRT-2359 exhibits preferential activity in MYC-driven cell lines.